Exposure Control Plan-Program Administration
- _________________________
is (are)
responsible for the implementation of the ECP. _____________________________
will
maintain, review, and update the ECP at least annually, and whenever necessary to include
new or modified tasks and procedures. Contact location/phone number:
___________________________________________________
- Those employees who are
determined to have
occupational exposure to blood or other potentially infectious material (OPIM) must comply
with the procedures and work practices outlines in this ECP.
- _______________________________
will maintain and
provide all necessary personal protective equipment (PPE), engineering controls (e.g.,
sharps containers), labels, and labeled or red bags as required by the standard.
______________________ will ensure that adequate supplies of the aforementioned equipment
are available in the appropriate sizes. Contact location/phone number:
_______________________________________________
- __________________________ will be responsible for
ensuring that all medical actions required are performed and that appropriate medical
records are maintained.
Contact location/phone number: ________________________________________
- __________________________ will be responsible for
training, documentation of training, and making the written ECP available to employees,
OSHA, and NIOSH representatives.
Contact location/phone number: ________________________________________
Notes to Employer:
The names or job titles of the program
administrators should be used to ensure that authority and responsibility have been
designated. In a small business, the responsibilities for the program may be held by
one individual. In this case, these duties can be combined.
"Other potentially infectious materials"
(OPIM) means (1) The following human body fluids: semen, vaginal secretions, cerebrospinal
fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid,
saliva in dental procedures, any body fluid that is visibly contaminated with blood, and
all body fluids in situations where it is difficult or impossible to differentiate between
body fluids; (2) Any unfixed tissue or organ (other than intact skin) from a human (living
or dead); and (3) HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBV-
containing culture medium or other solutions; and blood, organs, or other tissues from
experimental animals infected with HIV or HBV.
|
|
|